Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2006; Volume 186, Supplement 650
Joint Meeting of The German Society of Physiology and The Federation of European Physiological Societies 2006
3/26/2006-3/29/2006
Ludwig-Maximilians-University, Munich


CELLULAR CARDIOMYOPLASTY REDUCES VENTRICULAR VULNERABILITY IN THE INFARCTED MURINE HEART
Abstract number: OT02-7

Schrickel1 JW, Roll1 W, Becher1 U, Hashemi1 T, Breitbach1 M, Sasse1 P, Welz1 A, Lewalter1 T, Fleischmann1 BK

1Dept. of Medicine-Cardiology, University of Bonn

Ventricular arrhythmias and sudden death are a common complication of heart failure. Cellular cardiomyoplasty is thought to enhance left ventricular function, but it remains unclear if this therapy also improves cardiac electrical stability after myocardial infarction. Adult male mice underwent cryo-infarction and transplantation of electrically coupling embryonic cardiomyocytes (ECM) and non-coupling skeletal myoblasts (SMB). In vivo transvenous electrophysiological testing, including evaluation of the inducibility of ventricular tachycardia (VT) was performed in these and control (WT) mice. All non-treated, infarcted mice were susceptible to induction of VT. Transplantation of ECM strongly reduced VT-inducibility (37.5 %; p=0.0009) to control-level (WT: 40%). In contrast, the VTs deteriorated in the SMB-group (still 100% inducible; p=0.0011 vs. WT; p=0.0009 vs. ECM) as 4 mice developed persistent VTs and ventricular fibrillation; the VTs in all other groups were self-terminating. Hence, transplantation of electrically non-coupling SMB causes a deterioration of the electrical stability. Importantly, transplantation of ECM electrically stabilized the acutely injured mouse heart and may represent a novel therapeutic strategy for the treatment of malignant arrhythmias.

To cite this abstract, please use the following information:
Acta Physiologica 2006; Volume 186, Supplement 650 :OT02-7

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE